GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Short-Term Debt

Progen Co (XKRX:296160) Short-Term Debt : ₩26,746 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Progen Co Short-Term Debt?

Progen Co's Short-Term Debt for the quarter that ended in Dec. 2024 was ₩26,746 Mil.

Progen Co's quarterly Short-Term Debt increased from . 20 (₩0 Mil) to Dec. 2023 (₩28,144 Mil) but then declined from Dec. 2023 (₩28,144 Mil) to Dec. 2024 (₩26,746 Mil).

Progen Co's annual Short-Term Debt stayed the same from . 20 (₩0 Mil) to . 20 (₩0 Mil) but then increased from . 20 (₩0 Mil) to Dec. 2023 (₩28,144 Mil).

Progen Co Short-Term Debt Historical Data

The historical data trend for Progen Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progen Co Short-Term Debt Chart

Progen Co Annual Data
Trend Dec23
Short-Term Debt
28,143.63

Progen Co Quarterly Data
Dec23 Dec24
Short-Term Debt 28,143.63 26,746.34

Progen Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Progen Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Progen Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Progen Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Short-Term Debt
Comparable Companies
XKRX:222110 XKRX:299660 XKRX:348080 XKRX:261780 XKRX:038070 XKRX:308080 XKRX:168330 XKRX:383930 XKRX:046210 XKRX:456570 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
172 Magokjungang-ro, 7th Floor, Bio Innovation Park, Gangseo-gu, Seoul, KOR
Website
http://www.progen.co.kr
Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.

Progen Co Headlines

No Headlines